HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Thomas E Witzig Selected Research

Yttrium

7/2013A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
9/2007Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
5/2007Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
4/2006Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
12/2004Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.
2/2002Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Thomas E Witzig Research Topics

Disease

52Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2015 - 01/2002
48Neoplasms (Cancer)
07/2015 - 02/2002
29Lymphoma (Lymphomas)
01/2015 - 01/2002
29Multiple Myeloma
12/2013 - 07/2002
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
09/2015 - 07/2007
12Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015 - 07/2005
12Amyloidosis
06/2014 - 12/2003
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 11/2002
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2014 - 08/2005
10Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2014 - 01/2002
7B-Cell Lymphoma (Lymphoma, B Cell)
06/2013 - 01/2002
7Thrombocytopenia (Thrombopenia)
04/2011 - 06/2002
6Infection
07/2014 - 06/2002
6Disease Progression
10/2013 - 09/2002
5Colonic Neoplasms (Colon Cancer)
03/2007 - 09/2003
5Carcinoma (Carcinomatosis)
03/2007 - 05/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2011 - 09/2003
4Hodgkin Disease (Hodgkin's Disease)
05/2010 - 10/2005
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2008 - 04/2003
4Microsatellite Instability
03/2007 - 05/2006
3T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 10/2009
3Genetic Translocation (Chromosomal Translocation)
01/2015 - 09/2013
3Paraproteinemias (Monoclonal Gammopathy)
12/2011 - 01/2002
3Neutropenia
04/2011 - 07/2005
3Chromosome Aberrations (Chromosome Abnormalities)
02/2011 - 05/2003
3Monoclonal Gammopathy of Undetermined Significance
05/2007 - 07/2002
3Anemia
07/2005 - 01/2003
2Liver Diseases (Liver Disease)
08/2014 - 02/2004
2Pancreatitis
11/2013 - 03/2008
2Fatigue
04/2011 - 01/2007
2Hematologic Neoplasms (Hematological Malignancy)
11/2009 - 07/2006
2Sepsis (Septicemia)
02/2008 - 06/2002
2Aneuploidy (Aneuploid)
12/2006 - 09/2006

Drug/Important Bio-Agent (IBA)

35rituximab (Mabthera)FDA Link
09/2015 - 01/2002
19ibritumomab tiuxetan (Zevalin)FDA Link
07/2013 - 02/2002
11lenalidomide (CC 5013)FDA Link
01/2015 - 01/2007
11Sirolimus (Rapamycin)FDA Link
03/2012 - 08/2005
9Immunoglobulins (Immunoglobulin)IBA
01/2015 - 08/2005
8everolimusFDA Link
07/2015 - 07/2006
8Dexamethasone (Maxidex)FDA LinkGeneric
08/2011 - 11/2002
8Thalidomide (Thalomid)FDA Link
10/2010 - 11/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 12/2005
6Proteins (Proteins, Gene)IBA
06/2014 - 05/2005
6YttriumIBA
07/2013 - 02/2002
6Immunoglobulin M (IgM)IBA
05/2011 - 01/2002
6temsirolimusFDA Link
04/2011 - 08/2005
5Biological Markers (Surrogate Marker)IBA
01/2015 - 12/2006
5CytokinesIBA
12/2014 - 08/2004
5Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
06/2014 - 09/2008
4Vincristine (Oncovin)FDA LinkGeneric
09/2015 - 12/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 08/2011
4Cyclin D1IBA
10/2014 - 08/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 08/2004
4B-Cell Activating FactorIBA
05/2009 - 02/2006
4Phosphotransferases (Kinase)IBA
08/2008 - 05/2003
4CD20 AntigensIBA
03/2008 - 01/2006
4N-methylsuccinimideIBA
03/2007 - 05/2006
3Prednisone (Sone)FDA LinkGeneric
09/2015 - 10/2011
3alemtuzumab (Campath)FDA Link
01/2015 - 08/2003
3purineIBA
07/2014 - 06/2002
3bortezomib (Velcade)FDA Link
10/2013 - 07/2005
3Complement System Proteins (Complement)IBA
09/2012 - 10/2008
3Vitamin DFDA LinkGeneric
07/2012 - 09/2010
3Interleukin-12 (IL 12)IBA
04/2012 - 01/2002
3Interleukin-10 (Interleukin 10)IBA
03/2012 - 10/2009
3Interleukin-6 (Interleukin 6)IBA
11/2011 - 10/2003
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2010 - 07/2006
3DNA (Deoxyribonucleic Acid)IBA
03/2007 - 09/2006
2Interleukin-8 (Interleukin 8)IBA
12/2014 - 05/2007
2IfosfamideFDA LinkGeneric
08/2014 - 07/2007
2Carboplatin (JM8)FDA LinkGeneric
08/2014 - 07/2007
2Cisplatin (Platino)FDA LinkGeneric
08/2014 - 07/2007
2Mechlorethamine (Nitrogen Mustard)FDA Link
08/2014 - 02/2004
2InterferonsIBA
04/2014 - 09/2012
2ProMune (CpG 7909)IBA
07/2013 - 02/2012
2Anti-Bacterial Agents (Antibiotics)IBA
03/2013 - 06/2002
2hLL2 agent (epratuzumab)IBA
11/2012 - 10/2011
2NF-kappa B (NF-kB)IBA
05/2012 - 05/2008
2Immunoglobulin G (IgG)IBA
04/2011 - 03/2008
2hydroxide ionIBA
02/2011 - 09/2010
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2011 - 06/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2010 - 02/2004
2ridaforolimusIBA
01/2010 - 07/2006
2InterleukinsIBA
07/2009 - 10/2003
2CalciumIBA
05/2009 - 01/2003
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
05/2009 - 10/2004
2Alkylating AgentsIBA
09/2008 - 09/2007
2CladribineFDA LinkGeneric
07/2008 - 06/2002
26-Mercaptopurine (Mercaptopurine)FDA LinkGeneric
03/2008 - 01/2002
22-methoxyestradiolIBA
10/2007 - 12/2002
2Serum AlbuminIBA
03/2007 - 04/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2006 - 10/2005

Therapy/Procedure

23Radioimmunotherapy
09/2015 - 02/2002
18Drug Therapy (Chemotherapy)
04/2013 - 06/2002
7Stem Cell Transplantation
11/2014 - 12/2002
5Aftercare (After-Treatment)
09/2008 - 04/2003
3Transplants (Transplant)
06/2014 - 12/2005
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2006 - 05/2004
2Radiotherapy
09/2015 - 07/2005
2Therapeutics
01/2010 - 06/2006